| Own Slots |
| |
Slot Name |
Value |
 |
Alternatives |
ACE_inhibitors, Aldosterone_receptor_antagonists |
|
CanImprove |
Diastolic_hypertension, Morbidity, Mortality, Systolic_hypertension |
|
CautionWithMedicationsUsed |
|
|
Comment |
ACE inhibitors and ARBs have similar efficacy on mortality and morbidity in HF |
|
Contraindication |
Hyperkalemia, Severe_aortic_stenosis, Increased_creatinine, Bilateral_renal_artery_stenosis |
|
CouldBeRelatedTo |
Chronic_heart_failure, Acute_myocardial_infarction, Left_ventricular_systolic_dysfunction |
|
Cui |
C1449680 |
|
Definition |
Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. |
|
DespiteReceivingTreatment |
|
|
DoNotUseWithMedicationGroup |
|
|
EspeciallyEffectiveAgainst |
|
|
Improves |
|
|
Incrementsmgday |
|
|
InitiatingDose |
|
|
MaintenanceDose |
|
|
MaximumRecommendedDailyDose |
|
|
MeanDailyDose |
|
|
RelevantSignOrSymptom |
Coughing, Low_blood_pressure_disorder |
|
SideEffect |
Low_blood_pressure_disorder, Carotid_sinus_syncope, Renal_insufficiency, Hyperkalemia |
|
Synonyms |
ARB |
|
TargetDose |
|
|
TitrationPeriod |
Consider evry 2-4 weeks |
|
TreatmentStatus |
|
|
Treats |
|
|
UMLSSynonyms |
Angiotensine_II_type_1_receptor_blockers |
|
UsedTogetherWithMedication |
|
|
UsedWithMedicationGroup |
ACE_inhibitors |
|
UseWhenExistsIntoleranceOf |
|
|
UseWithTest |
|
